CATALOGO DEI PRODOTTI DELLA RICERCA

GAJOFATTO, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.365
EU - Europa 4.314
AS - Asia 2.124
AF - Africa 70
SA - Sud America 32
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 9
Totale 10.932
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.340
CN - Cina 1.344
GB - Regno Unito 1.132
IT - Italia 1.065
SG - Singapore 494
SE - Svezia 424
RU - Federazione Russa 370
FR - Francia 346
IE - Irlanda 302
FI - Finlandia 230
DE - Germania 219
VN - Vietnam 67
UA - Ucraina 56
EG - Egitto 46
KR - Corea 39
BE - Belgio 37
ID - Indonesia 30
IR - Iran 28
IN - India 22
NL - Olanda 22
CA - Canada 20
JP - Giappone 19
BR - Brasile 18
CZ - Repubblica Ceca 18
CH - Svizzera 17
TR - Turchia 17
AU - Australia 16
HK - Hong Kong 14
ES - Italia 13
TG - Togo 12
MK - Macedonia 11
GR - Grecia 9
IL - Israele 8
PK - Pakistan 8
EU - Europa 7
DK - Danimarca 6
NO - Norvegia 6
CL - Cile 5
SD - Sudan 5
EC - Ecuador 4
HU - Ungheria 4
JO - Giordania 4
LV - Lettonia 4
PL - Polonia 4
SA - Arabia Saudita 4
AT - Austria 3
CY - Cipro 3
DO - Repubblica Dominicana 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
CO - Colombia 2
KG - Kirghizistan 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LT - Lituania 2
LU - Lussemburgo 2
MA - Marocco 2
NZ - Nuova Zelanda 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
GE - Georgia 1
IM - Isola di Man 1
KZ - Kazakistan 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
SC - Seychelles 1
SI - Slovenia 1
TH - Thailandia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 10.932
Salva come PNG Salva come JPEG
Città #
Southend 987
Chandler 786
Ashburn 449
Singapore 419
Woodbridge 382
Ann Arbor 374
Jacksonville 331
Dublin 302
Beijing 243
Verona 193
Houston 147
New York 142
Wilmington 126
Lawrence 122
Princeton 122
Jinan 109
Nanjing 102
Helsinki 100
Hebei 88
Shenyang 88
Milan 74
Boardman 70
Washington 55
Tianjin 44
Dong Ket 43
Lancaster 43
Zhengzhou 43
Redwood City 42
Changsha 40
Ningbo 40
Brussels 37
Haikou 37
Nanchang 37
Hangzhou 36
Redmond 35
Taiyuan 30
Jakarta 29
Los Angeles 29
Sindelfingen 28
Taizhou 28
Rome 26
Guangzhou 25
Dallas 24
Seattle 24
Bologna 23
Cairo 23
Seoul 22
Fuzhou 21
Santa Clara 21
Dearborn 20
Falls Church 20
Tehran 20
Jiaxing 19
Norwalk 18
Padova 18
Naples 16
Olomouc 15
Catania 14
Clearwater 13
Columbus 13
Lanzhou 13
Florence 12
Lomé 12
Moscow 12
Shanghai 12
Tokyo 12
Düsseldorf 11
Kent 11
Seongbuk-gu 11
Skopje 11
Auburn Hills 10
Brescia 10
Plymouth 10
Riva 10
Tappahannock 10
Fairfield 9
Kemerovo 9
Dongguan 8
Hong Kong 8
Al Mansurah 7
Bisenti 7
Bolzano 7
Bronte 7
Genoa 7
Loreggia 7
Melbourne 7
Paris 7
Amsterdam 6
Arco 6
Bari 6
Lappeenranta 6
London 6
Phoenix 6
Romola 6
San Diego 6
Sassari 6
Cagliari 5
Catanzaro 5
Chicago 5
Chions 5
Totale 7.158
Salva come PNG Salva come JPEG
Nome #
Psicologia positiva e disabilità: affrontare le sfide del futuro nell'adulto con disabilità acquisita, cronica e progressiva 374
Tolebrutinib. Bruton tyrosine kinase (BTK) inhibitor Treatment of multiple sclerosis 359
Gestione degli eventi avversi dei farmaci modificanti il decorso della malattia nella sclerosi multipla 189
Un caso di sclerosi multipla con esordio "tumor-like" e decorso benigno 176
Analisi delle alterazioni funzionali dell’arto superiore e dell’attività muscolare mediante emgs in pazienti con sclerosi multipla: uno studio “cross-sectional” 151
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 144
Two sisters with Leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's Syndrome? 138
A randomized controlled trial of IV immunoglobulin in patients with postpolio syndrome. 136
Levofloxacin-induced hemichorea-hemiballism in a patient with previous thalamic infarction 124
Prevalence of multiple sclerosis in Verona, Italy: an epidemiologic and genetic study 123
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis. 122
QTc interval in patients with multiple sclerosis: an inference from the insula of Reil? 122
GLI EFFETTI DI DUE DIVERSI TIPI DI TRATTAMENTO MOTORIO SULLE FUNZIONI COGNITIVE IN PAZIENTI CON SCLEROSI MULTIPLA 120
A Case-control study of myelin oligodendrocyte glycoprotein and CD45 polymorphisms in multiple sclerosis in Verona, Italy 116
EFFETTI DI UN TRAINING DI INTEGRAZIONE SENSORI – MOTORIA SUI DISTURBI DELL’EQUILIBRIO IN PAZIENTI CON SCLEROSI MULTIPLA: UNO STUDIO RANDOMIZZATO CONTROLLATO 116
A case of multifocal CIS with unusual MRI features suggestive of Balo's concentric sclerosis 115
Intravenous immunoglobulin for post-polio syndrome: a randomized double-blind, placebo-controlled study 115
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 115
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 114
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 112
Cognitive onset in multiple sclerosis 111
Risk factors for post-polio syndrome among an Italian population: a case-control study. 110
An active case of radiologically isolated syndrome: from MRI detection to multiple sclerosis 105
High-intensity robot-assisted hand training in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 105
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients? 103
Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study. 102
A case of acute fulminant multiple sclerosis treated with alemtuzumab 102
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 102
Sensory integration balance training in patients with multiple sclerosis: A randomized, controlled trial 101
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 101
Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions 100
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 99
An exploratory panel of cerebrospinal fluid biomarkers compared to standard diagnostic evaluation in initial demyelinating events suggestive of multiple sclerosis 97
Clinical and demographic predictors of response to first-line therapies in relapsing-remitting multiple sclerosis 97
The diagnosis of multiple sclerosis: pinpointing the concept of "no better explanation" 97
EFFECTIVENESS OF A SENSORIMOTOR INTEGRATION TRAINING ON BALANCE DISORDERS IN PATIENTS WITH MULTIPLE SCLEROSIS: A RANDOMIZED CONTROLLED TRIAL 96
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 96
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 95
“If You Can’t Control the Wind, Adjust Your Sail”: Tips for Post-Pandemic Benefit Finding from Young Adults Living with Multiple Sclerosis. A Qualitative Study 95
HCV-related nervous system disorders. 94
Physical disability and cognitive impairment evolution in benign multiple sclerosis: a five years prospective study 94
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 92
Response to Nagai et al. 92
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 90
A bio-psycho-social co-created intervention for young adults with multiple sclerosis (ESPRIMO): rationale and study protocol for a feasibility study 90
Insights for fostering resilience in young adults with multiple sclerosis in the aftermath of the COVID-19 emergency: an Italian survey 90
Epilepsy in multiple sclerosis: The role of temporal lobe damage 90
Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. 89
A panel of exploratory CSF biomarkers in patients with an initial demyelinating event of the CNS: does it add relevant information to usual work-up? 89
Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study 89
Brentuximab vedotin: axonal microtubule's Apollyon 88
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis 88
A case of multiple sclerosis and necrotizing autoimmune myopathy with anti-SRP antibodies 88
Effects of high-intensity robot-assisted training in hand function recovery and adl independence in individuals with multiple sclerosis: A randomized controlled single-blinded trial 88
Two sisters with leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's syndrome? 86
2017 McDonald criteria for multiple sclerosis: Earlier diagnosis with reduced specificity? 86
HPV-related papillary squamous cell carcinoma of the tonsil during treatment with fingolimod 86
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 85
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review. 84
Physicochemical properties of Aβ peptides in cerebrospinal fluid of Alzheimer’s disease patients 84
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 84
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 84
Long lesions on initial spinal cord MRI predict a final diagnosis of acute disseminated encephalomyelitis versus multiple sclerosis in children 83
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 83
Increased cortical lesion load and CSF cytokines in oligoclonal band positive MS patients 83
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis 82
Characterization of Upper Limb Impairments at Body Function, Activity, and Participation in Persons With Multiple Sclerosis by Behavioral and EMG Assessment: A Cross-Sectional Study 81
Long survival and clinical stability in Marburg's variant multiple sclerosis. 80
Acute cardiovascular dysfunction in multiple sclerosis: report of two cases and literature review 80
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study. 79
Amyloid myopathy: an intriguing diagnosis 79
Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease. 78
Prognostic factors of acute partial transverse myelitis. 78
Early predictors of recovery, symptom recurrence, conversion to multiple sclerosis and long-term disability after acute myelitis 78
Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score. 77
Increased cerebrospinal fluid cystatin C may predict disability after acute myelitis 77
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 77
Assessing subjective quality of life domains after multiple sclerosis diagnosis disclosure 75
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis 74
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study) 74
Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder 74
e-ESPRIMO: An e-health biopsychosocial intervention for young adults with Multiple sclerosis and medium/high disability. Co-creation phase 72
Up-regulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients 72
Prognostic indicators of “benign” clinical course in multiple sclerosis patients. 71
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 70
Effects of high-intensity robot-assisted hand training on upper limb recovery and muscle activity in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 70
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 69
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 68
Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis. 67
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: an Italian multi-centre study 66
Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status 65
Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives 65
Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy. 63
Impact of switching first-line disease-modifying therapy after treatment failure in relapsing-remitting multiple sclerosis 63
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 63
Tumor-like multiple sclerosis: three cases misdiagnosed as primary brain neoplasm 62
Treatment strategies for multiple sclerosis: when to start, when to change, when to stop? 62
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 62
Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis: the evidence to date 61
Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, Italy 59
Totale 9.767
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.853
article - articoli 36.439
book - libri 0
conference - conferenze 1.269
curatela - curatele 0
other - altro 280
patent - brevetti 0
selected - selezionate 0
volume - volumi 865
Totale 77.706
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020542 0 0 0 0 0 0 153 30 52 114 91 102
2020/20211.169 142 223 79 116 137 103 28 41 65 35 104 96
2021/20221.177 98 418 31 123 27 23 11 74 36 32 74 230
2022/20232.274 153 291 212 372 175 483 30 142 246 30 88 52
2023/20241.867 65 114 181 157 241 402 92 154 20 107 178 156
2024/20251.380 169 200 201 486 174 148 2 0 0 0 0 0
Totale 11.141